Pharmacogenetic association between the formation of 4-hydroxymephenytoin and a new metabolite of S-mephenytoin in man
Wedlund, P.J.; Sweetman, B.J.; Wilkinson, G.R.; Branch, R.A.
Drug Metabolism and Disposition the Biological Fate of Chemicals 15(2): 277-279
1987
ISSN/ISBN: 0090-9556 PMID: 2882992 Document Number: 298392
Document emailed within 1 workday
Related Documents
Ginsburg, B.E.; Sze, P.Y. 1975: Pharmacogenetic studies of the serotonergic system in association with convulsive seizures in mice Psychopharmacology Bulletin 11(3): 29-30Eadsforth, C.V.; Logan, C.J.; Page, J.A.; Regan, P.D. 1985: N-Butylglycidyl ether: the formation of a novel metabolite of an epoxide Drug Metabolism and Disposition: the Biological Fate of Chemicals 13(2): 263-264
Pietrabissa, A.; Di Stefano, R.; Collecchi, P.; Campanella, P.G.; Della Capanna, S.; Scarcello, E.; Turini, L.; Bevilacqua, G.; Mosca, F. 1994: Effect of cyclosporine-A pretreatment on lidocaine metabolite formation in the regenerating rat liver Transplantation Proceedings 26(5): 2908-2909
Schlossmann, K.; Pütter, J. 1973: Studies on the formation of the lactone and acid form of the main metabolite of mefruside Arzneimittel-Forschung 23(2): 255-262
Houston, J.B.; Cassidy, M.K. 1982: Rate limiting steps in metabolite kinetics: formation of 5-acetylaminosalicylate after administration of 5-aminosalicylate Journal of Pharmacy and Pharmacology 34(8): 536-538
Grech-Bélanger, O.; Turgeon, J.; Lalande, M.; Bélanger, P.M. 1991: Meta-hydroxymexiletine, a new metabolite of mexiletine. Isolation, characterization, and species differences in its formation Drug Metabolism and Disposition: the Biological Fate of Chemicals 19(2): 458-461
Cummings, J.; Milroy, R. 1986: In vitro formation of a toxic aglycone metabolite of 4-demethoxydaunorubicin in conditions that parallel the stomach Anticancer Research 6(5): 1177-1179
Levine, M.; Bellward, G.D. 1995: Effect of cimetidine on hepatic cytochrome P450: evidence for formation of a metabolite-intermediate complex Drug Metabolism and Disposition: the Biological Fate of Chemicals 23(12): 1407-1411
Shaw, P.N.; Tseti, J.; Warburton, S.; Adedoyin, A.; Houston, J.B. 1986: Inhibition of antipyrine metabolite formation. Steady state studies with cimetidine and metyrapone in rats Drug Metabolism and Disposition: the Biological Fate of Chemicals 14(2): 271-276
Kahl, R.; Friederici, D.E.; Kahl, G.F.; Ritter, W.; Krebs, R. 1980: Clotrimazole as an inhibitor of benzo[a]pyrene metabolite-DNA adduct formation in vitro and of microsomal mono-oxygenase activity Drug Metabolism and Disposition: the Biological Fate of Chemicals 8(4): 191-196
Teunissen, M.W.; De Leede, L.G.; Boeijinga, J.K.; Breimer, D.D. 1985: Correlation between antipyrine metabolite formation and theophylline metabolism in humans after simultaneous single-dose administration and at steady state Journal of Pharmacology and Experimental Therapeutics 233(3): 770-775
Ding, J-Jie.; Jiao, Z.; Yu, Y-Qiu.; Shi, X-Jin. 2007: Development and identifiability analysis of parent-metabolite pharmacokinetic model for risperidone and its main active metabolite 9-hydroxyrisperidone Yao Xue Xue Bao 42(6): 631-638
Inaba, T. 1986: Genetic polymorphism of mephenytoin metabolism Progress in Clinical and Biological Research 214: 139-156
Huang, S.; Xie, H.; Wang, W.; Xu, Z.; Jiang, C.; Zhou, H. 1997: Determination of R- and S-mephenytoin in human urine by gas chromatography Se Pu 15(5): 408-410
Mutloane, M. 1996: The formation of one Medical Association of South Africa South African Medical Journal 86(8): 941
Komenda, S.; Macáková, J.; Hrbek, J. 1981: An operator model for the formation of the paired association Activitas Nervosa Superior 23(4): 283-284
Spencer, R.F. 1990: Spasticity in association with massive new bone formation around fractures South African Journal of Surgery. Suid-Afrikaanse Tydskrif Vir Chirurgie 28(2): 51-54
Hardwick, R.H.; Taylor, A.; Thompson, M.H.; Jones, E.; Roe, A.M. 2000: Association between Streptococcus milleri and abscess formation after appendicitis Annals of the Royal College of Surgeons of England 82(1): 24-26
Lynn, R.K.; Bauer, J.E.; Gordon, W.P.; Smith, R.G.; Griffin, D.; Thompson, R.M.; Jenkins, R.; Gerber, N. 1979: Characterization of mephenytoin metabolites in human urine by gas chromatography and mass spectrometry Drug Metabolism and Disposition: the Biological Fate of Chemicals 7(3): 138-144
Snead, C.; Siegel, N.; Hayslett, J. 1976: Generalized lymphadenopathy and nephrotic syndrome as a manifestation of mephenytoin (mesantoin) toxicity Pediatrics 57(1): 98-101